Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aspri Pharma Canada is a specialty pharmaceutical company dedicated to the commercialization and distribution of niche and essential medicines within the Canadian healthcare system. The company focuses primarily on therapeutic areas such as neurology and the central nervous system, providing access to critical treatments for epilepsy and other complex conditions. Aspri Pharma acts as a strategic partner for international manufacturers, leveraging its expertise in Canadian regulatory affairs, market access, and supply chain management. Their portfolio includes a range of established branded and generic products, including clobazam, nitrazepam, and ethosuximide. By focusing on legacy and specialty products, Aspri Pharma ensures that patients maintain access to vital medications that might otherwise be unavailable in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aspri Pharma Canada.